Skip to main content

Advertisement

Figure 6 | Malaria Journal

Figure 6

From: Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations

Figure 6

Competition Western blot analysis with lysates from P. falciparum blood stage parasites and recombinant GMZ2, MSP3 or GLURP. Total lysates of in vitro cultivated parasites were separated by SDS-PAGE under reducing conditions and blotted onto a nitrocellulose membrane. Serum of a NMRI mouse immunized with IRIV-formulated GMZ2 was pre-incubated with or without recombinant competitor protein and subsequently added to cut strips. Immune serum was used at a dilution of 1:2000 and competitors at a concentration of 1 μg/mL.

Back to article page